Users Stopping Anti-Obesity Injections Regain Weight at a Quadrupled Rate Than People Using Diet and Exercise

A recent study suggests that patients who come off blockbuster GLP-1 drugs like semaglutide or tirzepatide can put back on reduced body mass much more quickly than those who end conventional lifestyle regimens.

Findings released in a prominent medical journal points out that while obese people can lose about a fifth of their total mass while using the jabs, the weight comes back at an average rate of nearly a kilo each month after stopping.

"Individuals purchasing such drugs need to be cognizant of the danger of rapid weight regain when the medication ends," stated researcher Dr. Susan Jebb.

That rate of recovery suggests a reversion to starting mass in about one and a half years.

Weighing Treatments

The analysis, which examined dozens of studies involving thousands of patients, contrasted the effects of the injectable medications with other pills.

Researchers point out that people who shed pounds through dieting typically have a less rapid weight regain—approximately 0.1 kg a month—once they finish.

Explaining the Fast Rebound

Experts believe the way of the jabs accounts for the heightened rebound.

These medications mimic a natural hormone called GLP-1, which moderates appetite.

"Long-term administration of the hormone levels several times higher than the body's typical production might result in the system to produce less of its own natural hormone, and could reduce responsiveness to its actions," said Dr. Adam Collins, a nutrition expert.

"Stopping of this GLP-1 'fix' means appetite is unsuppressed, making overeating a significant risk."

A Chronic Condition?

Health authorities suggest the jabs for individuals with weight-linked medical conditions, accompanied by prescribed diet and exercise modifications.

Professionals say that, given the significant potential of weight regain, the treatment might need to be long-term.

This opinion is echoed by pharmaceutical companies, who state that the findings "emphasize the persistent character of obesity," similar to managing conditions like hypertension.

User Testimonies

Users who have stopped the medication report a intense resurgence of hunger.

"I experienced a trigger that goes on and I was suddenly starving," said a patient.

This difficulty is compounded if individuals have not developed lasting dietary or behavioural changes during treatment.

Widespread Use

Figures indicate that a significant number of people in the UK have used these injections in the last 12 months, with interest being substantial.

• Use is higher among females compared to males.
• The middle-aged demographic shows the highest level of interest.
• A large proportion obtain the drugs through private healthcare rather than the NHS.

Finally, experts emphasize that while the jabs are potent tools for weight loss, they are not a standalone solution and long-term success hinges on combined lifestyle management.